Nuedexta 20-10 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9DQF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,898
Award facts
- Contract value 100% obligated
- $13,897.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,897.72 to AmerisourceBergen Drug Corp for the supply of Nuedexta 20-10 mg capsules (60-count unit) on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price contract was awarded on a competitive basis with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Nuedexta is a prescription medication used to treat pseudobulbar affect, a neurological condition characterized by involuntary emotional expressions. This delivery order reflects AmerisourceBergen's critical role as a pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military treatment facilities. The contract demonstrates the company's capability to efficiently fulfill government requirements for specialized pharmaceutical products on a competitive basis through the DLA's comprehensive pharmaceutical supply chain vehicle.
Quick answers
Who was awarded contract SPE2DR26F9DQF?
SPE2DR26F9DQF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9DQF worth?
The government has obligated $13,898 on SPE2DR26F9DQF.
Is contract SPE2DR26F9DQF an order under another contract?
Yes. SPE2DR26F9DQF is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DQF competed?
The extent of competition for SPE2DR26F9DQF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award